An Open-labelled, Randomized, Controlled, Clinical Trial to Evaluate the Immunogenicity and Tolerability of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine
Latest Information Update: 16 Mar 2026
At a glance
- Drugs Poliovirus vaccine inactivated Intravacc/Sinovac/WHO (Primary)
- Indications Poliomyelitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sinovac Biotech
Most Recent Events
- 16 Mar 2026 New trial record